Clinical Trials Browser

Interventional × Has results × Resectable Esophageal Cancer × Clear all

NCT03490292 2024-07-26

Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

Phase 1/2 Completed

22 enrolled 17 charts

Gastrointestinal

Resectable Esophageal Cancer